...
首页> 外文期刊>Medicine. >Investigation of Endoscopic and Pathologic Features for Safe Endoscopic Treatment of Superficial Spreading Early Gastric Cancer
【24h】

Investigation of Endoscopic and Pathologic Features for Safe Endoscopic Treatment of Superficial Spreading Early Gastric Cancer

机译:安全内镜治疗浅表蔓延早期胃癌的内镜和病理特征研究

获取原文
获取原文并翻译 | 示例

摘要

Superficial spreading early gastric cancer (EGC) is a rare disease that is treated mainly by surgery. There are few studies on the safety of endoscopic treatment for patients with superficial spreading EGC. The aims of this study were to (1) investigate the risk of lymph node metastasis of superficial spreading EGC and (2) investigate the potential criteria for endoscopic treatment of superficial spreading EGC using surgical specimens.Between 2000 and 2010, patients who received curative surgery of R0 resection at Severance Hospital (Seoul, Korea) for early gastric cancer were enrolled. The superficial spreading EGC was defined as cancer in which the longest tumor length was 6cm. The medical records of the patients were reviewed retrospectively.Of the 3813 patients with EGC, 140 (3.7%) had lesions 6cm, whereas 3673 (96.3%) had lesions<6cm. Patients with superficial spreading EGC had higher rates of submucosal cancer (59.3% vs 45.7%, P=0.002), lymphovascular invasion (18.6% vs 9.8%, P<0.001), and lymph node metastasis (15.7% vs 10.1%, P=0.033) compared with patients with common EGC (< 6cm). Multivariate analysis revealed that a tumor 6cm was not strongly associated with lymph node metastasis in EGC, as compared with a tumor<6cm, but submucosal invasion and lymphovascular invasion were strongly associated with lymph node metastasis in EGC. In mucosal cancer without ulcers, tumors 6cm had a higher rate of lymph node metastasis than tumors 2cm; however, this trend was not significant (7.7% vs 5.3%, P=0.455).Superficial spreading EGC was not associated with an increased risk of lymph node metastasis compared with common EGC. We suggest that differentiated intramucosal superficial spreading EGC without ulceration can be treated by endoscopic submucosal dissection.
机译:表面展开早期胃癌(EGC)是一种罕见的疾病,主要通过手术治疗。浅谈浅表扩散EGC患者内镜治疗安全性的研究。本研究的目的是(1)探讨浅表扩散EGC的淋巴结转移的风险和(2)研究了使用外科标本的浅表扩散EGC的内窥镜治疗的潜在标准。2000年和2010年,接受治愈性手术的患者注册了育死医院(首尔,韩国)的R0切除术。浅表扩散EGC定义为癌症最长的肿瘤长度为6cm。回顾性审查患者的病程。根据EGC的3813名患者,140名(3.7%)有病灶6cm,而3673(96.3%)有病灶<6cm。浅表蔓延的患者具有较高的粘膜癌率(59.3%vs 45.7%,p = 0.002),淋巴血管侵袭(18.6%vs.9.8%,p <0.001)和淋巴结转移(15.7%vs10.1%,p = 0.033)与常见EGC(<6cm)的患者相比。多变量分析显示,与肿瘤<6cm相比,肿瘤6cm与EGC中的淋巴结转移强烈相关,但粘膜侵袭和淋巴血管侵袭与EGC中的淋巴结转移强烈相关。在没有溃疡的粘膜癌中,肿瘤6cm的淋巴结转移率比肿瘤2cm更高;然而,这种趋势并不重要(7.7%vs 5.3%,p = 0.455)。与普通EGC相比,胰扩散EGC与淋巴结转移的风险增加无关。我们建议通过内窥镜粘膜粘膜释放,对没有溃疡的肤浅的肤质展开EGC。

著录项

  • 来源
    《Medicine. 》 |2016年第14期| 共6页
  • 作者单位

    Yonsei Univ Dept Internal Med Wonju Coll Med Div Gastroenterol &

    Hepatol Wonju South Korea;

    Hallym Univ Dongtan Sacred Heart Hosp Dept Surg Hwasung South Korea;

    Yonsei Univ Dept Surg Coll Med Seoul South Korea;

    Yonsei Univ Dept Surg Coll Med Seoul South Korea;

    Yonsei Univ Dept Surg Coll Med Seoul South Korea;

    Hallym Univ Dongtan Sacred Heart Hosp Div Gastroenterol Hwasung South Korea;

    Yonsei Univ Dept Internal Med Wonju Coll Med Div Gastroenterol &

    Hepatol Wonju South Korea;

    Hallym Univ Dongtan Sacred Heart Hosp Div Gastroenterol Hwasung South Korea;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 医药、卫生 ;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号